🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉Congratulations to PC3I Fellow Debanjan Pain, MD, who received a 2024 ASCO Conquer Cancer, the ASCO Foundation Young Investigator Award for his work supporting patients with #prostatecancer in Sub-Saharan Africa. #ASCO24 pc3i.upenn.edu/pc3i-fellow-de…

Drawing attention to this remarkable story. Jamie received tumor-infiltrating lymphocyte (TIL) therapy from Dr. Rosenberg and team at the NIH Clinical Center more than 10 yrs ago. Today, she advocates for other #CancerSurvivors. @NCIResearchCtr cancercontrol.cancer.gov/ocs/resources/…

Check out Angie DeMichele, MD, MSCE, FASCO on Penn Medicine CureTalks podcast discussing breast cancer recurrence & the current ongoing efforts to prevent relapse! Watch here youtu.be/pbUXJpikIgQ?si…

In The New York Times article on double mastectomies Angie DeMichele, MD, MSCE, FASCO says removing the healthy breast does not prevent cancer from spreading to other areas of the body. “This is why chemotherapy and hormonal therapies are so important, they are designed to kill these cells” Read more 👇

This is a picture of hope. The ⁦The Breast Cancer Research Foundation⁩ funded researchers working to end breast cancer. I am living proof of their work. Thank you!!!

How can breast cancer patients lower their risk of recurrence? Watch Angie DeMichele, MD, MSCE, FASCO of Penn Medicine discuss with FollowHeidi & Shweta Mishra here: youtube.com/watch?v=pbUXJp… #BreastCancerAwarenessMonth #BreastCancerAwareness

In honor of #BreastCancerAwarenessMonth, Penn Medicine scheduled more than 120 mammograms as part of our annual Mammo-thon event at our downtown Philly hospitals. We are grateful to the providers and coordinators who helped patients and employees prioritize their breast health!

Read more about patient advocate Jamie LaScala incredible battle with triple-positive inflammatory breast cancer & her experience on Penn Medicine - Abramson Cancer Center breast cancer recurrence clinical trial led by Angie DeMichele, MD, MSCE, FASCO in TODAY article: today.com/health/breast-…

When #breastcancer patients are done with treatment, they may wonder about the disease coming back. That’s why breast cancer survivor Jamie LaScala joined a clinical trial led by Angie DeMichele, MD, MSCE, FASCO at Penn Medicine - Abramson Cancer Center aimed at preventing recurrence. TODAY spr.ly/6014SV1b2

I am honored to share that I am running for the ASCO Board of Directors open Medical Oncologist seat. Learn more about me and the 12 other remarkable candidates at asco.org/election, and cast your ballot! 🗳️

We’ve curated a list of the Top 100 #Xfluencers in #BreastCancer for 2024! Harold J. Burstein, MD, PhD, FASCO Ann Partridge MD, MPH Dr Sarah Sammons Hope Rugo Nancy Lin, MD Naoto T Ueno, MD, PhD Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Philippe Aftimos, MD  Dr Liz O'Riordan Carmen Criscitiello Amy Comander MD, DipABLM Angie DeMichele, MD, MSCE, FASCO Dr. Ariella Hanker Jo Taylor Felicia Knaul

New publication alert 🚨 : Penn researchers explore whether rates of guideline-concordant care, time to treatment initiation, and all-cause mortality in #BreastCancer differ by race among older adults. Brenda Castillo, MD Yehoda Martei MD, MSCE JAMA Network Open spr.ly/6011sDMBS

I am so honored and thrilled to be running for this seat. You can shape the future of ASCO - vote before December 3rd!!

Excellent presentation by Selina Luger: "Gilteritinib results in higher remission & transplant rates than midostaurin but does not increase the post-induction mutational MRD negative rate" per ph 2 randomized PrECOG Study in Newly Diagnosed FLT3 Mutated AML #ASH2024

Out Today: Outcomes in stage IIA vs stage IIB/III in the PALLAS trial at 4 yr follow-up. Angie DeMichele, MD, MSCE, FASCO 1st author. PrECOG is a collaborator on this international breast cancer trial led by Alliance Foundation Trials @Alliance_org …ast-cancer-research.biomedcentral.com/articles/10.11… Pfizer Oncology Medical

According to an American Cancer Society report, the incidence of many cancer types in women and younger adults is increasing. Our own Dr. Angie DeMichele, MD, MSCE, FASCO explained that oncologists have to be prepared to address challenges specific to younger patients. Medscape spr.ly/6013xMhnP

Learn more about 2-PREVENT Breast Cancer Translational Center of Excellence led by Angie DeMichele, MD, MSCE, FASCO & Univ. of Pennsylvania Department of Cancer Biology Chair Lewis Chodosh.

After surviving aggressive breast cancer, Illeana feared recurrence. Our Penn Medicine - Abramson Cancer Center 2-PREVENT TCE, led by Drs Angie DeMichele, MD, MSCE, FASCO & Lewis Chodosh, is working to eliminate DTCs-before they return. Read her story + the science behind it: 🔗 pennmedicine.org/news/keeping-c… #CancerResearch